Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer

Clinical and Experimental Metastasis

Volumn 29, Issue 6, 2012, Pages 615-624

  Schoppmann, Sebastian F ^a   Jesch, Bettina ^a   Friedrich, Julia ^a   Jomrich, Gerd ^a   Maroske, Florian ^a   Birner, Peter ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Esophageal cancer; Her 2; Prognosis; STAT3

Indexed keywords

CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR 2; STAT3 PROTEIN; TYROSINE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AGED; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHORYLATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TYROSINE;

EID: 84863717535     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9475-3     Document Type: Article

References (38)

1. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421
2. Darnell JE Jr (1997) STATs and gene regulation. Science 277: 1630-1635
3. Bromberg J, Darnell JE Jr (2000) The role of STATs in tran-scriptional control and their impact on cellular function. Onco-gene 19:2468-2473. doi:10.1038/sj.onc.1203476
4. Bowman T, Garcia R, Turkson J, Jove R (2000) STATs in oncogenesis. Oncogene 19:2474-2488. doi:10.1038/sj.onc.120 3527
5. Buettner R, Mora LB, Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8:945-954
6. Beguelin W, Diaz Flaque MC, Proietti CJ, Cayrol F, Rivas MA, Tkach M, Rosemblit C, Tocci JM, Charreau EH, Schillaci R, Elizalde PV (2010) Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel tran-scriptional effect: ErbB-2 function as a coactivator of Stat3. Mol Cell Biol 30:5456-5472. doi:10.1128/MCB.00012-10
7. Proietti CJ, Rosemblit C, Beguelin W, Rivas MA, Diaz Flaque MC, Charreau EH, Schillaci R, Elizalde PV (2009) Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth. Mol Cell Biol 29:1249-1265. doi:10.1128/MCB.00853-08
8. Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan MW, Marini FC, Rosol TJ, Bonafe M, Hall BM (2008) Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and inva-siveness in an interleukin-6-dependent manner. Cancer Res 68: 9087-9095. doi:10.1158/0008-5472.CAN-08-0400
9. Birner P, Jesch B, Friedrich J, Riegler M, Zacherl J, Hejna M, Wrba F, Schultheis A, Schoppmann SF (2011) Carbonic anhy-drase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Ann Surg Oncol 18:3330-3337. doi:10.1245/s10434-011-1730-3
10. Schoppmann SF, Jesch B, Friedrich J, Wrba F, Schultheis A, Pluschnig U, Maresch J, Zacherl J, Hejna M, Birner P (2010) Expression of Her-2 in carcinomas of the esophagus. Am J Surg Pathol 34:1868-1873. doi:10.1097/PAS. 0b013e3181f8be170000 0478-201012000-00016
11. Brien TP, Odze RD, Sheehan CE, McKenna BJ, Ross JS (2000) HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma. Hum Pathol 31:35-39
12. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Ku-likov E, Hill J, Lehle M, Ruschoff J, Kang YK (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesopha-geal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687-697. doi:10.1016/S0140-6736 (10)61121-X
13. Pham NA, Morrison A, Schwock J, Aviel-Ronen S, Iakovlev V, Tsao MS, Ho J, Hedley DW (2007) Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol 2:8. doi:10.1186/1746-1596-2-8
14. Schoppmann SF, Jesch B, Zacherl J, Wrba F, Hejna M, Maresch J, Langer FB, Riegler MF, Pluschnig U, Birner P (2011) HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases. Br J Surg 98:1408-1413. doi:10.1002/bjs.7562
15. Hu Y, Bandla S, Godfrey TE, Tan D, Luketich JD, Pennathur A, Qiu X, Hicks DG, Peters JH, Zhou Z (2011) HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Modern Pathol 24:899-907. doi:10.1038/modpathol.2011.47
16. Birner P, Toumangelova-Uzeir K, Natchev S, Guentchev M (2010) STAT3 tyrosine phosphorylation influences survival in glioblastoma. J Neurooncol 100:339-343. doi:10.1007/s11060-010-0195-8
17. Rudiger Siewert J, Feith M, Werner M, Stein HJ (2000) Ade-nocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1, 002 consecutive patients. Ann Surg 232:353-361
18. Kim T, Grobmyer SR, Smith R, Ben-David K, Ang D, Vogel SB, Hochwald SN (2010) Esophageal cancer-the five year survivors. J Surg Oncol 103:179-183. doi:10.1002/jso.21784
19. Zhong Z, Wen Z, Darnell JE Jr (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98
20. Karni R, Jove R, Levitzki A (1999) Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 18:4654-4662. doi:10.1038/sj.onc.1202835
21. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB (2002) Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62:3351-3355
22. Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR (2002) STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Differ 13:355-362
23. Sheen-Chen SM, Huang CC, Tang RP, Chou FF, Eng HL (2008) Prognostic value of signal transducers and activators of transcription 3 in breast cancer. Cancer Epidemiol Biomarkers Prev 17:2286-2290. doi:10.1158/1055-9965.EPI-08-0089
24. Torres-Roca JF, DeSilvio M, Mora LB, Khor LY, Hammond E, Ahmad N, Jove R, Forman J, Lee RJ, Sandler H, Pollack A (2007) Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10. Urology 69:505-509. doi:10.1016/j.urology.2006.11. 006
25. Min H, Wei-hong Z (2009) Constitutive activation of signal transducer and activatoroftranscription3in epithelial ovarian carcinoma. J Obstet Gynaecol Res 35:918-925. doi:10.1111/j.1447-0756. 2009.01045.x
26. Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB (2007) Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angio-genesis in head and neck squamous cell carcinoma. Oral Oncol 43:785-790. doi:10.1016/j.oraloncology.2006.10.007
27. Yakata Y, Nakayama T, Yoshizaki A, Kusaba T, Inoue K, Sekine I (2007) Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int J Oncol 30:437-442
28. Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS (2006) STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gas-troenterology 131:1073-1085. doi:10.1053/j.gastro.2006.07.018
29. Kim DY, Cha ST, Ahn DH, Kang HY, Kwon CI, Ko KH, Hwang SG, Park PW, Rim KS, Hong SP (2009) STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol 24:646-651. doi:10.1111/j.1440-1746.2008. 05671.x
30. Lee J, Kang WK, Park JO, Park SH, Park YS, Lim HY, Kim J, Kong J, Choi MG, Sohn TS, Noh JH, Bae JM, Kim S, Lim do H, Kim KM, Park CK (2009) Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS 117:598-606. doi: 10.1111/j.1600-0463.2009.02512.x
31. Dvorak K, Chavarria M, Payne CM, Ramsey L, Crowley-Weber C, Dvorakova B, Dvorak B, Bernstein H, Holubec H, Sampliner RE, Bernstein C, Prasad A, Green SB, Garewal H (2007) Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus. Clin Cancer Res 13:5305-5313. doi:10.1158/1078-0432.CCR-07-0483
32. Fernandes A, Hamburger AW, Gerwin BI (1999) ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells. Int J Cancer 83:564-570. doi:10.1002/(SICI)1097-0215(19991112)83:4\564:AID-IJC20[3.0. CO;2-Q
33. Lee C, Dhillon J, Wang MY, Gao Y, Hu K, Park E, Astanehe A, Hung MC, Eirew P, Eaves CJ, Dunn SE (2008) Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. Cancer Res 68:8661-8666. doi:10.1158/0008-5472.CAN-08-1082
34. Bonner JA, Trummell HQ, Willey CD, Plants BA, Raisch KP (2009) Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma. Radiother Oncol 92:339-344. doi:10.1016/j.radonc.2009.06.022
35. Costantino L, Barlocco D (2008) STAT 3 as a target for cancer drug discovery. Curr Med Chem 15:834-843
36. Heimberger AB, Kong LY, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Wei J, Qiao W, Schmittling RJ, Archer GE, Sampson JH, Hiraoka N, Priebe W, Fuller GN, Sawaya R (2009) The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clin Neurosurg 56:98-106
37. Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, Fokt I, Priebe W, Heimberger AB (2007) A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res 67:9630-9636. doi:10.1158/0008-5472.CAN-07-1243
38. Xin H, Zhang C, Herrmann A, Du Y, Figlin R, Yu H (2009) Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res 69:2506-2513. doi:10.1158/0008-5472. CAN-08-4323